The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis

Nature Medicine

Volumn 11, Issue 4, 2005, Pages 394-399

  Wada, Teiji ^a   Nakashima, Tomoki ^a   Oliveira Dos Santos, Antonio J ^b   Gasser, Juerg ^d   Hara, Hiromitsu ^a   Schett, Georg ^e   Penninger, Josef M ^a,c  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c AMGEN INC   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN GAB2; PROTEIN KINASE B; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SCAFFOLD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; BONE REMODELING; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE INACTIVATION; HOMEOSTASIS; HUMAN; HUMAN CELL; MORPHOGENESIS; MOUSE; NEWBORN; NONHUMAN; NORMAL HUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALIA;

ANIMALS; BONE REMODELING; BONE RESORPTION; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; MUTATION; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPETROSIS; PHOSPHOPROTEINS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION;

EID: 17644393474     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1203     Document Type: Article

References (28)

1. Baron, R. Molecular mechanisms of bone resorption: therapeutic implications. Rev. Rhum. Engl. Ed. 63, 633-638 (1996).
2. Suda, T. et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357 (1999).
3. Karsenty, G. & Wagner, E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389-406 (2002).
4. Boyle, W.J., Simonet, W.S. & Lacey, D.L. Osteoclast differentiation and activation. Nature 423, 337-342 (2003).
5. Kong, Y.Y. et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323 (1999).
6. Gu, H. & Neel, B.G. The 'Gab' in signal transduction. Trends Cell. Biol. 13, 122-130 (2003).
7. Hibi, M. & Hirano, T. Gab-family adapter molecules in signal transduction of cytokine and growth factor receptors, and T and B cell antigen receptors. Leuk. Lymphoma 37, 299-307 (2000).
8. Liu, Y. & Rohrschneider, L.R. The gift of Gab. FEBS Lett. 515, 1-7 (2002).
9. Holgado-Madruga, M., Emlet, D.R., Moscatello, D.K., Godwin, A.K. & Wong, A.J. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379, 560-564 (1996).
10. Sachs, M. et al. Essential role of Gab1 for signaling by the c-Met receptor in vivo. J. Cell. Biol. 150, 1375-1384 (2000).
11. Itoh, M. et al. Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation. Mol. Cell. Biol. 20, 3695-3704 (2000).
12. Seiffert, M. et al. Gab3-deficient mice exhibit normal development and hematopoiesis and are immunocompetent. Mol. Cell. Biol. 23, 2415-2424 (2003).
13. Gu, H. et al. Essential role for Gab2 in the allergic response. Nature 412, 186-190 (2001).
14. Nishida, K. et al. Requirement of Gab2 for mast cell development and KitL/c-Kit signaling. Blood 99, 1866-1869 (2002).
15. Gonzalez-Espinosa, C. et al. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J. Exp. Med. 197, 1453-1465 (2003).
16. Gu, H., Botelho, R.J., Yu, M., Grinstein, S. & Neel, B.G. Critical role for scaffolding adapter Gab2 in Fc gamma R-mediated phagocytosis. J. Cell. Biol. 161, 1151-1161 (2003).
17. Matsuzaki, K. et al. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem. Biophys. Res. Commun. 246, 199-204 (1998).
18. Yamasaki, S. et al. Docking protein Gab2 is phosphorylated by ZAP-70 and negatively regulates T cell receptor signaling by recruitment of inhibitory molecules. J. Biol. Chem. 276, 45175-45183 (2001).
19. Koga, T. et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428, 758-763 (2004).
20. Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901(2002).
21. Teitelbaum, S.L. & Ross, F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638-649 (2003).
22. Lomaga, M.A. et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13, 1015-1024(1999).
23. Theill, L.E., Boyle, W.J. & Penninger, J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20, 795-823 (2002).
24. Li, J. et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. USA 97, 1566-1571 (2000).
25. David, J.P., Sabapathy, K., Hoffmann, O., Idarraga, M.H. & Wagner, E.F. Jnk1 modulates osteoclastogenesis through both c-Jun phosphorylation- dependent and -independent mechanisms. J. Cell Sci. 115, 4317-4325 (2002).
26. Nakamura, I. et al. Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption. FEBS Lett. 361, 79-84 (1995).
27. Takeshita, S. et al. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat. Med. 8, 943-949 (2002).
28. Iotsova, V. et al. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3, 1285-1289 (1997).